SMDP.Y logo

Sumitomo Pharma OTCPK:SMDP.Y Stock Report

Last Price

US$4.10

Market Cap

US$1.5b

7D

0%

1Y

n/a

Updated

29 Nov, 2024

Data

Company Financials +

Sumitomo Pharma Co., Ltd.

OTCPK:SMDP.Y Stock Report

Market Cap: US$1.5b

SMDP.Y Stock Overview

Engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. More details

SMDP.Y fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Sumitomo Pharma Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sumitomo Pharma
Historical stock prices
Current Share PriceJP¥4.10
52 Week HighJP¥4.38
52 Week LowJP¥1.99
Beta0.63
11 Month Change-6.18%
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-49.19%

Recent News & Updates

Recent updates

Shareholder Returns

SMDP.YUS PharmaceuticalsUS Market
7D0%2.6%0.5%
1Yn/a13.1%30.7%

Return vs Industry: Insufficient data to determine how SMDP.Y performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how SMDP.Y performed against the US Market.

Price Volatility

Is SMDP.Y's price volatile compared to industry and market?
SMDP.Y volatility
SMDP.Y Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.9%
Market Average Movement6.3%
10% most volatile stocks in US Market16.3%
10% least volatile stocks in US Market3.1%

Stable Share Price: SMDP.Y's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine SMDP.Y's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
18974,980Toru Kimurawww.sumitomo-pharma.com

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson’s disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It provides products for atypical antipsychotic, cultured thymus tissue for pediatric congenital athymia, antiepileptic, and carbapenem antibiotic; and Fabry disease drugs.

Sumitomo Pharma Co., Ltd. Fundamentals Summary

How do Sumitomo Pharma's earnings and revenue compare to its market cap?
SMDP.Y fundamental statistics
Market capUS$1.53b
Earnings (TTM)-US$1.85b
Revenue (TTM)US$2.26b

0.7x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SMDP.Y income statement (TTM)
RevenueJP¥342.67b
Cost of RevenueJP¥138.58b
Gross ProfitJP¥204.08b
Other ExpensesJP¥483.54b
Earnings-JP¥279.46b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Jan 31, 2025

Earnings per share (EPS)-703.41
Gross Margin59.56%
Net Profit Margin-81.55%
Debt/Equity Ratio340.8%

How did SMDP.Y perform over the long term?

See historical performance and comparison